Medical Care
Global Drug Abuse Treatment Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jul 08, 25
- ID: 353509
- Pages: 119
- Figures: 117
- Views: 11
In 2024, the global market size of Drug Abuse Treatment was estimated to be worth US$ 20630 million and is forecast to reach approximately US$ 32070 million by 2031 with a CAGR of 6.6% during the forecast period 2025-2031.
Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
North America is the largest Drug Abuse Treatment market with about 48% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy"s Laboratories, Teva Pharmaceutical, PLIVA (Odyssey) etc. Top 5 companies occupied about 14% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Abuse Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Abuse Treatment.
The Drug Abuse Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Abuse Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Abuse Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical
PLIVA (Odyssey)
Segment by Type
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence
Segment by Application
Hospital & Clinics
Residential (non-hospital)
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Drug Abuse Treatment in global and regional level.
Chapter 3: Detailed analysis of Drug Abuse Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Abuse Treatment revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
North America is the largest Drug Abuse Treatment market with about 48% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy"s Laboratories, Teva Pharmaceutical, PLIVA (Odyssey) etc. Top 5 companies occupied about 14% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Abuse Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Abuse Treatment.
The Drug Abuse Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Abuse Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Abuse Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical
PLIVA (Odyssey)
Segment by Type
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence
Segment by Application
Hospital & Clinics
Residential (non-hospital)
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Drug Abuse Treatment in global and regional level.
Chapter 3: Detailed analysis of Drug Abuse Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Abuse Treatment revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Drug Abuse Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Drug Abuse Treatment Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Opioid Addiction
1.2.3 Tobacco/Nicotine Addiction
1.2.4 Alcohol Dependence
1.3 Market by Application
1.3.1 Global Drug Abuse Treatment Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital & Clinics
1.3.3 Residential (non-hospital)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Drug Abuse Treatment Market Size Estimates and Forecasts
2.2 Drug Abuse Treatment Market Size by Region: 2024 Versus 2031
2.2.1 Global Drug Abuse Treatment Revenue by Region: 2020-2025
2.2.2 Global Drug Abuse Treatment Revenue Forecast by Region (2026-2031)
2.2.3 Global Drug Abuse Treatment Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Drug Abuse Treatment Revenue by Type (2020-2031)
3.1.2 Global Drug Abuse Treatment Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Drug Abuse Treatment Revenue by Application (2020-2031)
3.2.2 Global Drug Abuse Treatment Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Opioid Addiction of Drug Abuse Treatment Revenue Market Share by Application
3.3.2 Tobacco/Nicotine Addiction of Drug Abuse Treatment Revenue Market Share by Application
3.3.3 Alcohol Dependence of Drug Abuse Treatment Revenue Market Share by Application
4 Global Drug Abuse Treatment by Company
4.1 Global Drug Abuse Treatment Revenue by Company (2020-2025)
4.2 Global Drug Abuse Treatment Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Drug Abuse Treatment Companies around the World: Ranking by Revenue
4.3.2 Global Drug Abuse Treatment Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Drug Abuse Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Drug Abuse Treatment Companies Headquarters & Product Type
4.4.1 Global Drug Abuse Treatment Companies Headquarters
4.4.2 Date of International Companies Enter into Drug Abuse Treatment Market
4.4.3 Global Drug Abuse Treatment Companies Product & Service
4.4.4 Opioid Addiction Revenue Market Share of Drug Abuse Treatment by Company
4.4.5 Tobacco/Nicotine Addiction Revenue Market Share of Drug Abuse Treatment by Company
4.4.6 Alcohol Dependence Revenue Market Share of Drug Abuse Treatment by Company
4.5 Global Drug Abuse Treatment Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Indivior
5.1.1 Indivior Corporation Information
5.1.2 Indivior Description, Business Overview
5.1.3 Indivior Drug Abuse Treatment Products Offered
5.1.4 Indivior Drug Abuse Treatment Revenue and Gross Margin (2020-2025)
5.1.5 Indivior Drug Abuse Treatment Revenue by Product in 2024
5.1.6 Indivior Drug Abuse Treatment Revenue by Application in 2024
5.1.7 Indivior Drug Abuse Treatment Revenue by Geographic Area in 2024
5.1.8 Indivior Recent Developments
5.2 Pfizer
5.2.1 Pfizer Corporation Information
5.2.2 Pfizer Description, Business Overview
5.2.3 Pfizer Drug Abuse Treatment Products Offered
5.2.4 Pfizer Drug Abuse Treatment Revenue and Gross Margin (2020-2025)
5.2.5 Pfizer Drug Abuse Treatment Revenue by Product in 2024
5.2.6 Pfizer Drug Abuse Treatment Revenue by Application in 2024
5.2.7 Pfizer Drug Abuse Treatment Revenue by Geographic Area in 2024
5.2.8 Pfizer Recent Developments
5.3 Alkermes
5.3.1 Alkermes Corporation Information
5.3.2 Alkermes Description, Business Overview
5.3.3 Alkermes Drug Abuse Treatment Products Offered
5.3.4 Alkermes Drug Abuse Treatment Revenue and Gross Margin (2020-2025)
5.3.5 Alkermes Drug Abuse Treatment Revenue by Product in 2024
5.3.6 Alkermes Drug Abuse Treatment Revenue by Application in 2024
5.3.7 Alkermes Drug Abuse Treatment Revenue by Geographic Area in 2024
5.3.8 Alkermes Recent Developments
5.4 Novartis
5.4.1 Novartis Corporation Information
5.4.2 Novartis Description, Business Overview
5.4.3 Novartis Drug Abuse Treatment Products Offered
5.4.4 Novartis Drug Abuse Treatment Revenue and Gross Margin (2020-2025)
5.4.5 Novartis Drug Abuse Treatment Revenue by Product in 2024
5.4.6 Novartis Drug Abuse Treatment Revenue by Application in 2024
5.4.7 Novartis Drug Abuse Treatment Revenue by Geographic Area in 2024
5.4.8 Novartis Recent Developments
5.5 Mylan
5.5.1 Mylan Corporation Information
5.5.2 Mylan Description, Business Overview
5.5.3 Mylan Drug Abuse Treatment Products Offered
5.5.4 Mylan Drug Abuse Treatment Revenue and Gross Margin (2020-2025)
5.5.5 Mylan Drug Abuse Treatment Revenue by Product in 2024
5.5.6 Mylan Drug Abuse Treatment Revenue by Application in 2024
5.5.7 Mylan Drug Abuse Treatment Revenue by Geographic Area in 2024
5.5.8 Mylan Recent Developments
5.6 Cipla
5.6.1 Cipla Corporation Information
5.6.2 Cipla Description, Business Overview
5.6.3 Cipla Drug Abuse Treatment Products Offered
5.6.4 Cipla Drug Abuse Treatment Revenue and Gross Margin (2020-2025)
5.6.5 Cipla Drug Abuse Treatment Revenue by Product in 2024
5.6.6 Cipla Drug Abuse Treatment Revenue by Application in 2024
5.6.7 Cipla Drug Abuse Treatment Revenue by Geographic Area in 2024
5.6.8 Cipla Recent Developments
5.7 Glenmark
5.7.1 Glenmark Corporation Information
5.7.2 Glenmark Description, Business Overview
5.7.3 Glenmark Drug Abuse Treatment Products Offered
5.7.4 Glenmark Drug Abuse Treatment Revenue and Gross Margin (2020-2025)
5.7.5 Glenmark Drug Abuse Treatment Revenue by Product in 2024
5.7.6 Glenmark Drug Abuse Treatment Revenue by Application in 2024
5.7.7 Glenmark Drug Abuse Treatment Revenue by Geographic Area in 2024
5.7.8 Glenmark Recent Developments
5.8 Dr. Reddy's Laboratories
5.8.1 Dr. Reddy's Laboratories Corporation Information
5.8.2 Dr. Reddy's Laboratories Description, Business Overview
5.8.3 Dr. Reddy's Laboratories Drug Abuse Treatment Products Offered
5.8.4 Dr. Reddy's Laboratories Drug Abuse Treatment Revenue and Gross Margin (2020-2025)
5.8.5 Dr. Reddy's Laboratories Drug Abuse Treatment Revenue by Product in 2024
5.8.6 Dr. Reddy's Laboratories Drug Abuse Treatment Revenue by Application in 2024
5.8.7 Dr. Reddy's Laboratories Drug Abuse Treatment Revenue by Geographic Area in 2024
5.8.8 Dr. Reddy's Laboratories Recent Developments
5.9 Teva Pharmaceutical
5.9.1 Teva Pharmaceutical Corporation Information
5.9.2 Teva Pharmaceutical Description, Business Overview
5.9.3 Teva Pharmaceutical Drug Abuse Treatment Products Offered
5.9.4 Teva Pharmaceutical Drug Abuse Treatment Revenue and Gross Margin (2020-2025)
5.9.5 Teva Pharmaceutical Drug Abuse Treatment Revenue by Product in 2024
5.9.6 Teva Pharmaceutical Drug Abuse Treatment Revenue by Application in 2024
5.9.7 Teva Pharmaceutical Drug Abuse Treatment Revenue by Geographic Area in 2024
5.9.8 Teva Pharmaceutical Recent Developments
5.10 PLIVA (Odyssey)
5.10.1 PLIVA (Odyssey) Corporation Information
5.10.2 PLIVA (Odyssey) Description, Business Overview
5.10.3 PLIVA (Odyssey) Drug Abuse Treatment Products Offered
5.10.4 PLIVA (Odyssey) Drug Abuse Treatment Revenue and Gross Margin (2020-2025)
5.10.5 PLIVA (Odyssey) Drug Abuse Treatment Revenue by Product in 2024
5.10.6 PLIVA (Odyssey) Drug Abuse Treatment Revenue by Application in 2024
5.10.7 PLIVA (Odyssey) Drug Abuse Treatment Revenue by Geographic Area in 2024
5.10.8 PLIVA (Odyssey) Recent Developments
6 North America
6.1 North America Drug Abuse Treatment Market Size YoY Growth 2020-2031
6.2 North America Drug Abuse Treatment Market Facts & Figures by Country (2020-2031)
6.3 North America Drug Abuse Treatment Revenue by Type (2020-2025)
6.4 North America Drug Abuse Treatment Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Drug Abuse Treatment Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Drug Abuse Treatment Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Drug Abuse Treatment Revenue by Type (2020-2025)
7.4 Asia-Pacific Drug Abuse Treatment Revenue by Application (2020-2025)
8 Europe
8.1 Europe Drug Abuse Treatment Market Size YoY Growth 2020-2031
8.2 Europe Drug Abuse Treatment Market Facts & Figures by Country (2020-2031)
8.3 Europe Drug Abuse Treatment Revenue by Type (2020-2025)
8.4 Europe Drug Abuse Treatment Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Drug Abuse Treatment Market Size YoY Growth 2020-2031
9.2 Latin America Drug Abuse Treatment Market Facts & Figures by Country (2020-2031)
9.3 Latin America Drug Abuse Treatment Revenue by Type (2020-2025)
9.4 Latin America Drug Abuse Treatment Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Drug Abuse Treatment Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Drug Abuse Treatment Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Drug Abuse Treatment Revenue by Type (2020-2025)
10.4 Middle East and Africa Drug Abuse Treatment Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Drug Abuse Treatment Supply Chain Analysis
11.2 Drug Abuse Treatment Key Raw Materials and Upstream Suppliers
11.3 Drug Abuse Treatment Clients Analysis
11.4 Drug Abuse Treatment Sales Channel and Sales Model Analysis
11.4.1 Drug Abuse Treatment Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Drug Abuse Treatment Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Drug Abuse Treatment Distributors
12 Drug Abuse Treatment Market Dynamics
12.1 Drug Abuse Treatment Industry Trends
12.2 Drug Abuse Treatment Market Drivers
12.3 Drug Abuse Treatment Market Challenges
12.4 Drug Abuse Treatment Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Drug Abuse Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Drug Abuse Treatment Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Opioid Addiction
1.2.3 Tobacco/Nicotine Addiction
1.2.4 Alcohol Dependence
1.3 Market by Application
1.3.1 Global Drug Abuse Treatment Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital & Clinics
1.3.3 Residential (non-hospital)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Drug Abuse Treatment Market Size Estimates and Forecasts
2.2 Drug Abuse Treatment Market Size by Region: 2024 Versus 2031
2.2.1 Global Drug Abuse Treatment Revenue by Region: 2020-2025
2.2.2 Global Drug Abuse Treatment Revenue Forecast by Region (2026-2031)
2.2.3 Global Drug Abuse Treatment Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Drug Abuse Treatment Revenue by Type (2020-2031)
3.1.2 Global Drug Abuse Treatment Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Drug Abuse Treatment Revenue by Application (2020-2031)
3.2.2 Global Drug Abuse Treatment Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Opioid Addiction of Drug Abuse Treatment Revenue Market Share by Application
3.3.2 Tobacco/Nicotine Addiction of Drug Abuse Treatment Revenue Market Share by Application
3.3.3 Alcohol Dependence of Drug Abuse Treatment Revenue Market Share by Application
4 Global Drug Abuse Treatment by Company
4.1 Global Drug Abuse Treatment Revenue by Company (2020-2025)
4.2 Global Drug Abuse Treatment Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Drug Abuse Treatment Companies around the World: Ranking by Revenue
4.3.2 Global Drug Abuse Treatment Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Drug Abuse Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Drug Abuse Treatment Companies Headquarters & Product Type
4.4.1 Global Drug Abuse Treatment Companies Headquarters
4.4.2 Date of International Companies Enter into Drug Abuse Treatment Market
4.4.3 Global Drug Abuse Treatment Companies Product & Service
4.4.4 Opioid Addiction Revenue Market Share of Drug Abuse Treatment by Company
4.4.5 Tobacco/Nicotine Addiction Revenue Market Share of Drug Abuse Treatment by Company
4.4.6 Alcohol Dependence Revenue Market Share of Drug Abuse Treatment by Company
4.5 Global Drug Abuse Treatment Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Indivior
5.1.1 Indivior Corporation Information
5.1.2 Indivior Description, Business Overview
5.1.3 Indivior Drug Abuse Treatment Products Offered
5.1.4 Indivior Drug Abuse Treatment Revenue and Gross Margin (2020-2025)
5.1.5 Indivior Drug Abuse Treatment Revenue by Product in 2024
5.1.6 Indivior Drug Abuse Treatment Revenue by Application in 2024
5.1.7 Indivior Drug Abuse Treatment Revenue by Geographic Area in 2024
5.1.8 Indivior Recent Developments
5.2 Pfizer
5.2.1 Pfizer Corporation Information
5.2.2 Pfizer Description, Business Overview
5.2.3 Pfizer Drug Abuse Treatment Products Offered
5.2.4 Pfizer Drug Abuse Treatment Revenue and Gross Margin (2020-2025)
5.2.5 Pfizer Drug Abuse Treatment Revenue by Product in 2024
5.2.6 Pfizer Drug Abuse Treatment Revenue by Application in 2024
5.2.7 Pfizer Drug Abuse Treatment Revenue by Geographic Area in 2024
5.2.8 Pfizer Recent Developments
5.3 Alkermes
5.3.1 Alkermes Corporation Information
5.3.2 Alkermes Description, Business Overview
5.3.3 Alkermes Drug Abuse Treatment Products Offered
5.3.4 Alkermes Drug Abuse Treatment Revenue and Gross Margin (2020-2025)
5.3.5 Alkermes Drug Abuse Treatment Revenue by Product in 2024
5.3.6 Alkermes Drug Abuse Treatment Revenue by Application in 2024
5.3.7 Alkermes Drug Abuse Treatment Revenue by Geographic Area in 2024
5.3.8 Alkermes Recent Developments
5.4 Novartis
5.4.1 Novartis Corporation Information
5.4.2 Novartis Description, Business Overview
5.4.3 Novartis Drug Abuse Treatment Products Offered
5.4.4 Novartis Drug Abuse Treatment Revenue and Gross Margin (2020-2025)
5.4.5 Novartis Drug Abuse Treatment Revenue by Product in 2024
5.4.6 Novartis Drug Abuse Treatment Revenue by Application in 2024
5.4.7 Novartis Drug Abuse Treatment Revenue by Geographic Area in 2024
5.4.8 Novartis Recent Developments
5.5 Mylan
5.5.1 Mylan Corporation Information
5.5.2 Mylan Description, Business Overview
5.5.3 Mylan Drug Abuse Treatment Products Offered
5.5.4 Mylan Drug Abuse Treatment Revenue and Gross Margin (2020-2025)
5.5.5 Mylan Drug Abuse Treatment Revenue by Product in 2024
5.5.6 Mylan Drug Abuse Treatment Revenue by Application in 2024
5.5.7 Mylan Drug Abuse Treatment Revenue by Geographic Area in 2024
5.5.8 Mylan Recent Developments
5.6 Cipla
5.6.1 Cipla Corporation Information
5.6.2 Cipla Description, Business Overview
5.6.3 Cipla Drug Abuse Treatment Products Offered
5.6.4 Cipla Drug Abuse Treatment Revenue and Gross Margin (2020-2025)
5.6.5 Cipla Drug Abuse Treatment Revenue by Product in 2024
5.6.6 Cipla Drug Abuse Treatment Revenue by Application in 2024
5.6.7 Cipla Drug Abuse Treatment Revenue by Geographic Area in 2024
5.6.8 Cipla Recent Developments
5.7 Glenmark
5.7.1 Glenmark Corporation Information
5.7.2 Glenmark Description, Business Overview
5.7.3 Glenmark Drug Abuse Treatment Products Offered
5.7.4 Glenmark Drug Abuse Treatment Revenue and Gross Margin (2020-2025)
5.7.5 Glenmark Drug Abuse Treatment Revenue by Product in 2024
5.7.6 Glenmark Drug Abuse Treatment Revenue by Application in 2024
5.7.7 Glenmark Drug Abuse Treatment Revenue by Geographic Area in 2024
5.7.8 Glenmark Recent Developments
5.8 Dr. Reddy's Laboratories
5.8.1 Dr. Reddy's Laboratories Corporation Information
5.8.2 Dr. Reddy's Laboratories Description, Business Overview
5.8.3 Dr. Reddy's Laboratories Drug Abuse Treatment Products Offered
5.8.4 Dr. Reddy's Laboratories Drug Abuse Treatment Revenue and Gross Margin (2020-2025)
5.8.5 Dr. Reddy's Laboratories Drug Abuse Treatment Revenue by Product in 2024
5.8.6 Dr. Reddy's Laboratories Drug Abuse Treatment Revenue by Application in 2024
5.8.7 Dr. Reddy's Laboratories Drug Abuse Treatment Revenue by Geographic Area in 2024
5.8.8 Dr. Reddy's Laboratories Recent Developments
5.9 Teva Pharmaceutical
5.9.1 Teva Pharmaceutical Corporation Information
5.9.2 Teva Pharmaceutical Description, Business Overview
5.9.3 Teva Pharmaceutical Drug Abuse Treatment Products Offered
5.9.4 Teva Pharmaceutical Drug Abuse Treatment Revenue and Gross Margin (2020-2025)
5.9.5 Teva Pharmaceutical Drug Abuse Treatment Revenue by Product in 2024
5.9.6 Teva Pharmaceutical Drug Abuse Treatment Revenue by Application in 2024
5.9.7 Teva Pharmaceutical Drug Abuse Treatment Revenue by Geographic Area in 2024
5.9.8 Teva Pharmaceutical Recent Developments
5.10 PLIVA (Odyssey)
5.10.1 PLIVA (Odyssey) Corporation Information
5.10.2 PLIVA (Odyssey) Description, Business Overview
5.10.3 PLIVA (Odyssey) Drug Abuse Treatment Products Offered
5.10.4 PLIVA (Odyssey) Drug Abuse Treatment Revenue and Gross Margin (2020-2025)
5.10.5 PLIVA (Odyssey) Drug Abuse Treatment Revenue by Product in 2024
5.10.6 PLIVA (Odyssey) Drug Abuse Treatment Revenue by Application in 2024
5.10.7 PLIVA (Odyssey) Drug Abuse Treatment Revenue by Geographic Area in 2024
5.10.8 PLIVA (Odyssey) Recent Developments
6 North America
6.1 North America Drug Abuse Treatment Market Size YoY Growth 2020-2031
6.2 North America Drug Abuse Treatment Market Facts & Figures by Country (2020-2031)
6.3 North America Drug Abuse Treatment Revenue by Type (2020-2025)
6.4 North America Drug Abuse Treatment Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Drug Abuse Treatment Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Drug Abuse Treatment Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Drug Abuse Treatment Revenue by Type (2020-2025)
7.4 Asia-Pacific Drug Abuse Treatment Revenue by Application (2020-2025)
8 Europe
8.1 Europe Drug Abuse Treatment Market Size YoY Growth 2020-2031
8.2 Europe Drug Abuse Treatment Market Facts & Figures by Country (2020-2031)
8.3 Europe Drug Abuse Treatment Revenue by Type (2020-2025)
8.4 Europe Drug Abuse Treatment Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Drug Abuse Treatment Market Size YoY Growth 2020-2031
9.2 Latin America Drug Abuse Treatment Market Facts & Figures by Country (2020-2031)
9.3 Latin America Drug Abuse Treatment Revenue by Type (2020-2025)
9.4 Latin America Drug Abuse Treatment Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Drug Abuse Treatment Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Drug Abuse Treatment Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Drug Abuse Treatment Revenue by Type (2020-2025)
10.4 Middle East and Africa Drug Abuse Treatment Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Drug Abuse Treatment Supply Chain Analysis
11.2 Drug Abuse Treatment Key Raw Materials and Upstream Suppliers
11.3 Drug Abuse Treatment Clients Analysis
11.4 Drug Abuse Treatment Sales Channel and Sales Model Analysis
11.4.1 Drug Abuse Treatment Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Drug Abuse Treatment Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Drug Abuse Treatment Distributors
12 Drug Abuse Treatment Market Dynamics
12.1 Drug Abuse Treatment Industry Trends
12.2 Drug Abuse Treatment Market Drivers
12.3 Drug Abuse Treatment Market Challenges
12.4 Drug Abuse Treatment Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Drug Abuse Treatment Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Drug Abuse Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Drug Abuse Treatment Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Drug Abuse Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Drug Abuse Treatment Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Drug Abuse Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Drug Abuse Treatment Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Drug Abuse Treatment Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Drug Abuse Treatment Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Drug Abuse Treatment Revenue by Company (2020-2025) & (US$ Million)
Table 11. Drug Abuse Treatment Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Drug Abuse Treatment Players by Revenue (US$ Million) in 2024
Table 13. Global Drug Abuse Treatment Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Drug Abuse Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Abuse Treatment as of 2024)
Table 15. Global Drug Abuse Treatment Companies Headquarters
Table 16. Date of International Companies Enter into Drug Abuse Treatment Market
Table 17. Global Drug Abuse Treatment Companies Product & Service
Table 18. Global Drug Abuse Treatment Mergers & Acquisitions, Expansion Plans
Table 19. Indivior Corporation Information
Table 20. Indivior Description and Business Overview
Table 21. Indivior Drug Abuse Treatment Product
Table 22. Indivior Drug Abuse Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Indivior Revenue Proportion of Drug Abuse Treatment by Product in 2024
Table 24. Indivior Revenue Proportion of Drug Abuse Treatment by Application in 2024
Table 25. Indivior Revenue Proportion of Drug Abuse Treatment by Geographic Area in 2024
Table 26. Indivior Recent Developments
Table 27. Pfizer Corporation Information
Table 28. Pfizer Description and Business Overview
Table 29. Pfizer Drug Abuse Treatment Product
Table 30. Pfizer Drug Abuse Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Pfizer Revenue Proportion of Drug Abuse Treatment by Product in 2024
Table 32. Pfizer Revenue Proportion of Drug Abuse Treatment by Application in 2024
Table 33. Pfizer Revenue Proportion of Drug Abuse Treatment by Geographic Area in 2024
Table 34. Pfizer Recent Developments
Table 35. Alkermes Corporation Information
Table 36. Alkermes Description and Business Overview
Table 37. Alkermes Drug Abuse Treatment Product
Table 38. Alkermes Drug Abuse Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Alkermes Revenue Proportion of Drug Abuse Treatment by Product in 2024
Table 40. Alkermes Revenue Proportion of Drug Abuse Treatment by Application in 2024
Table 41. Alkermes Revenue Proportion of Drug Abuse Treatment by Geographic Area in 2024
Table 42. Alkermes Recent Developments
Table 43. Novartis Corporation Information
Table 44. Novartis Description and Business Overview
Table 45. Novartis Drug Abuse Treatment Product
Table 46. Novartis Drug Abuse Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Novartis Revenue Proportion of Drug Abuse Treatment by Product in 2024
Table 48. Novartis Revenue Proportion of Drug Abuse Treatment by Application in 2024
Table 49. Novartis Revenue Proportion of Drug Abuse Treatment by Geographic Area in 2024
Table 50. Novartis Recent Developments
Table 51. Mylan Corporation Information
Table 52. Mylan Description and Business Overview
Table 53. Mylan Drug Abuse Treatment Product
Table 54. Mylan Drug Abuse Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Mylan Revenue Proportion of Drug Abuse Treatment by Product in 2024
Table 56. Mylan Revenue Proportion of Drug Abuse Treatment by Application in 2024
Table 57. Mylan Revenue Proportion of Drug Abuse Treatment by Geographic Area in 2024
Table 58. Mylan Recent Developments
Table 59. Cipla Corporation Information
Table 60. Cipla Description and Business Overview
Table 61. Cipla Drug Abuse Treatment Product
Table 62. Cipla Drug Abuse Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Cipla Revenue Proportion of Drug Abuse Treatment by Product in 2024
Table 64. Cipla Revenue Proportion of Drug Abuse Treatment by Application in 2024
Table 65. Cipla Revenue Proportion of Drug Abuse Treatment by Geographic Area in 2024
Table 66. Cipla Recent Developments
Table 67. Glenmark Corporation Information
Table 68. Glenmark Description and Business Overview
Table 69. Glenmark Drug Abuse Treatment Product
Table 70. Glenmark Drug Abuse Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Glenmark Revenue Proportion of Drug Abuse Treatment by Product in 2024
Table 72. Glenmark Revenue Proportion of Drug Abuse Treatment by Application in 2024
Table 73. Glenmark Revenue Proportion of Drug Abuse Treatment by Geographic Area in 2024
Table 74. Glenmark Recent Developments
Table 75. Dr. Reddy's Laboratories Corporation Information
Table 76. Dr. Reddy's Laboratories Description and Business Overview
Table 77. Dr. Reddy's Laboratories Drug Abuse Treatment Product
Table 78. Dr. Reddy's Laboratories Drug Abuse Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Dr. Reddy's Laboratories Revenue Proportion of Drug Abuse Treatment by Product in 2024
Table 80. Dr. Reddy's Laboratories Revenue Proportion of Drug Abuse Treatment by Application in 2024
Table 81. Dr. Reddy's Laboratories Revenue Proportion of Drug Abuse Treatment by Geographic Area in 2024
Table 82. Dr. Reddy's Laboratories Recent Developments
Table 83. Teva Pharmaceutical Corporation Information
Table 84. Teva Pharmaceutical Description and Business Overview
Table 85. Teva Pharmaceutical Drug Abuse Treatment Product
Table 86. Teva Pharmaceutical Drug Abuse Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Teva Pharmaceutical Revenue Proportion of Drug Abuse Treatment by Product in 2024
Table 88. Teva Pharmaceutical Revenue Proportion of Drug Abuse Treatment by Application in 2024
Table 89. Teva Pharmaceutical Revenue Proportion of Drug Abuse Treatment by Geographic Area in 2024
Table 90. Teva Pharmaceutical Recent Developments
Table 91. PLIVA (Odyssey) Corporation Information
Table 92. PLIVA (Odyssey) Description and Business Overview
Table 93. PLIVA (Odyssey) Drug Abuse Treatment Product
Table 94. PLIVA (Odyssey) Drug Abuse Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. PLIVA (Odyssey) Revenue Proportion of Drug Abuse Treatment by Product in 2024
Table 96. PLIVA (Odyssey) Revenue Proportion of Drug Abuse Treatment by Application in 2024
Table 97. PLIVA (Odyssey) Revenue Proportion of Drug Abuse Treatment by Geographic Area in 2024
Table 98. PLIVA (Odyssey) Recent Developments
Table 99. North America Drug Abuse Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 100. North America Drug Abuse Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 101. North America Drug Abuse Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 102. North America Drug Abuse Treatment Revenue by Application (2020-2025) & (US$ Million)
Table 103. Asia-Pacific Drug Abuse Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 104. Asia-Pacific Drug Abuse Treatment Revenue by Region (2026-2031) & (US$ Million)
Table 105. Asia-Pacific Drug Abuse Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 106. Asia-Pacific Drug Abuse Treatment Revenue by Application (2020-2025) & (US$ Million)
Table 107. Europe Drug Abuse Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 108. Europe Drug Abuse Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 109. Europe Drug Abuse Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 110. Europe Drug Abuse Treatment Revenue by Application (2020-2025) & (US$ Million)
Table 111. Latin America Drug Abuse Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 112. Latin America Drug Abuse Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 113. Latin America Drug Abuse Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 114. Latin America Drug Abuse Treatment Revenue by Application (2020-2025) & (US$ Million)
Table 115. Middle East and Africa Drug Abuse Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 116. Middle East and Africa Drug Abuse Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 117. Middle East and Africa Drug Abuse Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 118. Middle East and Africa Drug Abuse Treatment Revenue by Application (2020-2025) & (US$ Million)
Table 119. Drug Abuse Treatment Key Raw Materials, Industry Status and Trend
Table 120. Drug Abuse Treatment Key Raw Materials and Upstream Suppliers
Table 121. Drug Abuse Treatment Clients Status and Trend
Table 122. Drug Abuse Treatment Typical Clients
Table 123. Drug Abuse Treatment Distributors
Table 124. Drug Abuse Treatment Market Trends
Table 125. Drug Abuse Treatment Market Drivers
Table 126. Drug Abuse Treatment Market Challenges
Table 127. Drug Abuse Treatment Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Abuse Treatment Product Picture
Figure 2. Global Drug Abuse Treatment Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Drug Abuse Treatment Revenue Market Share by Type in 2024 & 2031
Figure 4. Opioid Addiction Product Picture
Figure 5. Tobacco/Nicotine Addiction Product Picture
Figure 6. Alcohol Dependence Product Picture
Figure 7. Global Drug Abuse Treatment Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Drug Abuse Treatment Revenue Market Share by Application in 2024 & 2031
Figure 9. Hospital & Clinics
Figure 10. Residential (non-hospital)
Figure 11. Drug Abuse Treatment Report Years Considered
Figure 12. Global Drug Abuse Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Drug Abuse Treatment Market Size (2020-2031) & (US$ Million)
Figure 14. Global Drug Abuse Treatment Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Drug Abuse Treatment Revenue Market Share by Region (2020-2031)
Figure 16. Global Drug Abuse Treatment Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Drug Abuse Treatment Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Opioid Addiction of Drug Abuse Treatment Revenue Market Share by Application, 2024 VS 2031
Figure 19. Tobacco/Nicotine Addiction of Drug Abuse Treatment Revenue Market Share by Application, 2024 VS 2031
Figure 20. Alcohol Dependence of Drug Abuse Treatment Revenue Market Share by Application, 2024 VS 2031
Figure 21. Drug Abuse Treatment Revenue Share by Company (2024)
Figure 22. Drug Abuse Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Opioid Addiction Revenue Proportion by Company in 2024
Figure 24. Tobacco/Nicotine Addiction Revenue Proportion by Company in 2024
Figure 25. Alcohol Dependence Revenue Proportion by Company in 2024
Figure 26. North America Drug Abuse Treatment Revenue 2020-2031 (US$ Million)
Figure 27. North America Drug Abuse Treatment Revenue Market Share by Type (2020-2025)
Figure 28. North America Drug Abuse Treatment Revenue Market Share by Application (2020-2025)
Figure 29. Asia-Pacific Drug Abuse Treatment Revenue 2020-2031 (US$ Million)
Figure 30. Asia-Pacific Drug Abuse Treatment Revenue Market Share by Region (2020-2031)
Figure 31. Asia-Pacific Drug Abuse Treatment Revenue Market Share by Type (2020-2025)
Figure 32. Asia-Pacific Drug Abuse Treatment Revenue Market Share by Application (2020-2025)
Figure 33. Europe Drug Abuse Treatment Revenue Growth Rate 2020-2031 (US$ Million)
Figure 34. Europe Drug Abuse Treatment Revenue Market Share by Country (2020-2031)
Figure 35. Europe Drug Abuse Treatment Revenue Market Share by Type (2020-2025)
Figure 36. Europe Drug Abuse Treatment Revenue Market Share by Application (2020-2025)
Figure 37. Latin America Drug Abuse Treatment Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Latin America Drug Abuse Treatment Revenue Market Share by Country (2020-2031)
Figure 39. Latin America Drug Abuse Treatment Revenue Market Share by Type (2020-2025)
Figure 40. Latin America Drug Abuse Treatment Revenue Market Share by Application (2020-2025)
Figure 41. Middle East and Africa Drug Abuse Treatment Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Middle East and Africa Drug Abuse Treatment Revenue Market Share by Country (2020-2031)
Figure 43. Middle East and Africa Drug Abuse Treatment Revenue Market Share by Type (2020-2025)
Figure 44. Middle East and Africa Drug Abuse Treatment Revenue Market Share by Application (2020-2025)
Figure 45. Drug Abuse Treatment Supply Chain (Upstream and Downstream Market)
Figure 46. Global Production Market Share of Drug Abuse Treatment Raw Materials by Region in 2024
Figure 47. Drug Abuse Treatment Distribution Channels
Figure 48. Global Drug Abuse Treatment Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 49. Global Drug Abuse Treatment Percentage 2020-2031: Online Sales VS Offline Sales
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Table 1. Global Drug Abuse Treatment Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Drug Abuse Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Drug Abuse Treatment Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Drug Abuse Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Drug Abuse Treatment Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Drug Abuse Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Drug Abuse Treatment Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Drug Abuse Treatment Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Drug Abuse Treatment Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Drug Abuse Treatment Revenue by Company (2020-2025) & (US$ Million)
Table 11. Drug Abuse Treatment Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Drug Abuse Treatment Players by Revenue (US$ Million) in 2024
Table 13. Global Drug Abuse Treatment Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Drug Abuse Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Abuse Treatment as of 2024)
Table 15. Global Drug Abuse Treatment Companies Headquarters
Table 16. Date of International Companies Enter into Drug Abuse Treatment Market
Table 17. Global Drug Abuse Treatment Companies Product & Service
Table 18. Global Drug Abuse Treatment Mergers & Acquisitions, Expansion Plans
Table 19. Indivior Corporation Information
Table 20. Indivior Description and Business Overview
Table 21. Indivior Drug Abuse Treatment Product
Table 22. Indivior Drug Abuse Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Indivior Revenue Proportion of Drug Abuse Treatment by Product in 2024
Table 24. Indivior Revenue Proportion of Drug Abuse Treatment by Application in 2024
Table 25. Indivior Revenue Proportion of Drug Abuse Treatment by Geographic Area in 2024
Table 26. Indivior Recent Developments
Table 27. Pfizer Corporation Information
Table 28. Pfizer Description and Business Overview
Table 29. Pfizer Drug Abuse Treatment Product
Table 30. Pfizer Drug Abuse Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Pfizer Revenue Proportion of Drug Abuse Treatment by Product in 2024
Table 32. Pfizer Revenue Proportion of Drug Abuse Treatment by Application in 2024
Table 33. Pfizer Revenue Proportion of Drug Abuse Treatment by Geographic Area in 2024
Table 34. Pfizer Recent Developments
Table 35. Alkermes Corporation Information
Table 36. Alkermes Description and Business Overview
Table 37. Alkermes Drug Abuse Treatment Product
Table 38. Alkermes Drug Abuse Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Alkermes Revenue Proportion of Drug Abuse Treatment by Product in 2024
Table 40. Alkermes Revenue Proportion of Drug Abuse Treatment by Application in 2024
Table 41. Alkermes Revenue Proportion of Drug Abuse Treatment by Geographic Area in 2024
Table 42. Alkermes Recent Developments
Table 43. Novartis Corporation Information
Table 44. Novartis Description and Business Overview
Table 45. Novartis Drug Abuse Treatment Product
Table 46. Novartis Drug Abuse Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Novartis Revenue Proportion of Drug Abuse Treatment by Product in 2024
Table 48. Novartis Revenue Proportion of Drug Abuse Treatment by Application in 2024
Table 49. Novartis Revenue Proportion of Drug Abuse Treatment by Geographic Area in 2024
Table 50. Novartis Recent Developments
Table 51. Mylan Corporation Information
Table 52. Mylan Description and Business Overview
Table 53. Mylan Drug Abuse Treatment Product
Table 54. Mylan Drug Abuse Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Mylan Revenue Proportion of Drug Abuse Treatment by Product in 2024
Table 56. Mylan Revenue Proportion of Drug Abuse Treatment by Application in 2024
Table 57. Mylan Revenue Proportion of Drug Abuse Treatment by Geographic Area in 2024
Table 58. Mylan Recent Developments
Table 59. Cipla Corporation Information
Table 60. Cipla Description and Business Overview
Table 61. Cipla Drug Abuse Treatment Product
Table 62. Cipla Drug Abuse Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Cipla Revenue Proportion of Drug Abuse Treatment by Product in 2024
Table 64. Cipla Revenue Proportion of Drug Abuse Treatment by Application in 2024
Table 65. Cipla Revenue Proportion of Drug Abuse Treatment by Geographic Area in 2024
Table 66. Cipla Recent Developments
Table 67. Glenmark Corporation Information
Table 68. Glenmark Description and Business Overview
Table 69. Glenmark Drug Abuse Treatment Product
Table 70. Glenmark Drug Abuse Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Glenmark Revenue Proportion of Drug Abuse Treatment by Product in 2024
Table 72. Glenmark Revenue Proportion of Drug Abuse Treatment by Application in 2024
Table 73. Glenmark Revenue Proportion of Drug Abuse Treatment by Geographic Area in 2024
Table 74. Glenmark Recent Developments
Table 75. Dr. Reddy's Laboratories Corporation Information
Table 76. Dr. Reddy's Laboratories Description and Business Overview
Table 77. Dr. Reddy's Laboratories Drug Abuse Treatment Product
Table 78. Dr. Reddy's Laboratories Drug Abuse Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Dr. Reddy's Laboratories Revenue Proportion of Drug Abuse Treatment by Product in 2024
Table 80. Dr. Reddy's Laboratories Revenue Proportion of Drug Abuse Treatment by Application in 2024
Table 81. Dr. Reddy's Laboratories Revenue Proportion of Drug Abuse Treatment by Geographic Area in 2024
Table 82. Dr. Reddy's Laboratories Recent Developments
Table 83. Teva Pharmaceutical Corporation Information
Table 84. Teva Pharmaceutical Description and Business Overview
Table 85. Teva Pharmaceutical Drug Abuse Treatment Product
Table 86. Teva Pharmaceutical Drug Abuse Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Teva Pharmaceutical Revenue Proportion of Drug Abuse Treatment by Product in 2024
Table 88. Teva Pharmaceutical Revenue Proportion of Drug Abuse Treatment by Application in 2024
Table 89. Teva Pharmaceutical Revenue Proportion of Drug Abuse Treatment by Geographic Area in 2024
Table 90. Teva Pharmaceutical Recent Developments
Table 91. PLIVA (Odyssey) Corporation Information
Table 92. PLIVA (Odyssey) Description and Business Overview
Table 93. PLIVA (Odyssey) Drug Abuse Treatment Product
Table 94. PLIVA (Odyssey) Drug Abuse Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. PLIVA (Odyssey) Revenue Proportion of Drug Abuse Treatment by Product in 2024
Table 96. PLIVA (Odyssey) Revenue Proportion of Drug Abuse Treatment by Application in 2024
Table 97. PLIVA (Odyssey) Revenue Proportion of Drug Abuse Treatment by Geographic Area in 2024
Table 98. PLIVA (Odyssey) Recent Developments
Table 99. North America Drug Abuse Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 100. North America Drug Abuse Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 101. North America Drug Abuse Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 102. North America Drug Abuse Treatment Revenue by Application (2020-2025) & (US$ Million)
Table 103. Asia-Pacific Drug Abuse Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 104. Asia-Pacific Drug Abuse Treatment Revenue by Region (2026-2031) & (US$ Million)
Table 105. Asia-Pacific Drug Abuse Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 106. Asia-Pacific Drug Abuse Treatment Revenue by Application (2020-2025) & (US$ Million)
Table 107. Europe Drug Abuse Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 108. Europe Drug Abuse Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 109. Europe Drug Abuse Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 110. Europe Drug Abuse Treatment Revenue by Application (2020-2025) & (US$ Million)
Table 111. Latin America Drug Abuse Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 112. Latin America Drug Abuse Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 113. Latin America Drug Abuse Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 114. Latin America Drug Abuse Treatment Revenue by Application (2020-2025) & (US$ Million)
Table 115. Middle East and Africa Drug Abuse Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 116. Middle East and Africa Drug Abuse Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 117. Middle East and Africa Drug Abuse Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 118. Middle East and Africa Drug Abuse Treatment Revenue by Application (2020-2025) & (US$ Million)
Table 119. Drug Abuse Treatment Key Raw Materials, Industry Status and Trend
Table 120. Drug Abuse Treatment Key Raw Materials and Upstream Suppliers
Table 121. Drug Abuse Treatment Clients Status and Trend
Table 122. Drug Abuse Treatment Typical Clients
Table 123. Drug Abuse Treatment Distributors
Table 124. Drug Abuse Treatment Market Trends
Table 125. Drug Abuse Treatment Market Drivers
Table 126. Drug Abuse Treatment Market Challenges
Table 127. Drug Abuse Treatment Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Abuse Treatment Product Picture
Figure 2. Global Drug Abuse Treatment Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Drug Abuse Treatment Revenue Market Share by Type in 2024 & 2031
Figure 4. Opioid Addiction Product Picture
Figure 5. Tobacco/Nicotine Addiction Product Picture
Figure 6. Alcohol Dependence Product Picture
Figure 7. Global Drug Abuse Treatment Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Drug Abuse Treatment Revenue Market Share by Application in 2024 & 2031
Figure 9. Hospital & Clinics
Figure 10. Residential (non-hospital)
Figure 11. Drug Abuse Treatment Report Years Considered
Figure 12. Global Drug Abuse Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Drug Abuse Treatment Market Size (2020-2031) & (US$ Million)
Figure 14. Global Drug Abuse Treatment Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Drug Abuse Treatment Revenue Market Share by Region (2020-2031)
Figure 16. Global Drug Abuse Treatment Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Drug Abuse Treatment Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Opioid Addiction of Drug Abuse Treatment Revenue Market Share by Application, 2024 VS 2031
Figure 19. Tobacco/Nicotine Addiction of Drug Abuse Treatment Revenue Market Share by Application, 2024 VS 2031
Figure 20. Alcohol Dependence of Drug Abuse Treatment Revenue Market Share by Application, 2024 VS 2031
Figure 21. Drug Abuse Treatment Revenue Share by Company (2024)
Figure 22. Drug Abuse Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Opioid Addiction Revenue Proportion by Company in 2024
Figure 24. Tobacco/Nicotine Addiction Revenue Proportion by Company in 2024
Figure 25. Alcohol Dependence Revenue Proportion by Company in 2024
Figure 26. North America Drug Abuse Treatment Revenue 2020-2031 (US$ Million)
Figure 27. North America Drug Abuse Treatment Revenue Market Share by Type (2020-2025)
Figure 28. North America Drug Abuse Treatment Revenue Market Share by Application (2020-2025)
Figure 29. Asia-Pacific Drug Abuse Treatment Revenue 2020-2031 (US$ Million)
Figure 30. Asia-Pacific Drug Abuse Treatment Revenue Market Share by Region (2020-2031)
Figure 31. Asia-Pacific Drug Abuse Treatment Revenue Market Share by Type (2020-2025)
Figure 32. Asia-Pacific Drug Abuse Treatment Revenue Market Share by Application (2020-2025)
Figure 33. Europe Drug Abuse Treatment Revenue Growth Rate 2020-2031 (US$ Million)
Figure 34. Europe Drug Abuse Treatment Revenue Market Share by Country (2020-2031)
Figure 35. Europe Drug Abuse Treatment Revenue Market Share by Type (2020-2025)
Figure 36. Europe Drug Abuse Treatment Revenue Market Share by Application (2020-2025)
Figure 37. Latin America Drug Abuse Treatment Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Latin America Drug Abuse Treatment Revenue Market Share by Country (2020-2031)
Figure 39. Latin America Drug Abuse Treatment Revenue Market Share by Type (2020-2025)
Figure 40. Latin America Drug Abuse Treatment Revenue Market Share by Application (2020-2025)
Figure 41. Middle East and Africa Drug Abuse Treatment Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Middle East and Africa Drug Abuse Treatment Revenue Market Share by Country (2020-2031)
Figure 43. Middle East and Africa Drug Abuse Treatment Revenue Market Share by Type (2020-2025)
Figure 44. Middle East and Africa Drug Abuse Treatment Revenue Market Share by Application (2020-2025)
Figure 45. Drug Abuse Treatment Supply Chain (Upstream and Downstream Market)
Figure 46. Global Production Market Share of Drug Abuse Treatment Raw Materials by Region in 2024
Figure 47. Drug Abuse Treatment Distribution Channels
Figure 48. Global Drug Abuse Treatment Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 49. Global Drug Abuse Treatment Percentage 2020-2031: Online Sales VS Offline Sales
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232